J Webster, G Piscitelli, A Polli, CI Ferrari, I … - New England Journal of Medicine, 1994 - content.nejm.org Methods A total of 459 women with hyperprolactinemic amenorrhea were treated
with either cabergoline (0.5 to 1.0 mg twice weekly) or bromocriptine (2.5 to
5.0 mg twice daily), administered in a double-blind fashion for 8 weeks and ... Cited by 284 - Related articles - BL Direct - All 8 versions
ML Vance, AG Harris - Archives of Internal Medicine, 1991 - archinte.highwire.org Background: We wanted to determine the clinical and bio- chemical effects of
long-term therapywith the somatostatin ana- log octreotide in 189 acromegalic
patients. Methods: Patients were treated at 23 medical centers for 6 daysto ... Cited by 192 - Related articles - All 3 versions
ME Molitch - Annual review of medicine, 1989 - Annual Reviews Prolactin (PRL) is secreted episodically so that the finding of minimally
elevated levels in blood requires confirmation in several samples. A number of
medical conditions and medications can cause hyperprolactinemia (Table I); ... Cited by 140 - Related articles - BL Direct - All 7 versions
- ►pipex.com [PDF] A Colao, A Di Sarno, P Cappabianca, C Di … - New England Journal of Medicine, 2003 - content.nejm.org From the Departments of Molecular and Clinical Endocrinology and Oncology, Sec-
tion of Endocrinology (AC, ADS, CDS, RP, GL), and Neurologic Sciences, Sec- tion
of Neurosurgery (PC) — all at Feder- ico II University of Naples, Naples, ... Cited by 114 - Related articles - BL Direct - All 9 versions
MP Gillam, ME Molitch, G Lombardi, A Colao - Endocrine reviews, 2006 - Endocrine Soc Prolactinomas account for approximately 40% of all pituitary adenomas and are an
important cause of hypogonadism and infertility. The ultimate goal of therapy
for prolactinomas is restoration or achievement of eugonadism through the ... Cited by 105 - Related articles - BL Direct - All 9 versions
- ►nih.gov [PDF] JL Jameson, A Klibanski, PM Black, NT … - Journal of Clinical Investigation, 1987 - pubmedcentral.nih.gov Approximately 25% of patients with pituitary adenomas have no clinical or
biochemical evidence for excess hormone secre- tion and are classified as having
null cell or nonfunctioning adenomas. To characterize the cell type of ... Cited by 84 - Related articles - All 5 versions
NH Caskey, ME Jarvik, WC Wirshing - Experimental and Clinical Psychopharmacology, 1999 - psycnet.apa.org Researchers have hypothesized that dopamine mediates the reinforcing effects of
stimulant drugs, including nicotine. Three experiments tested whether
manipulating dopamine would alter human smoking behavior. Experiments used ... Cited by 39 - Related articles - BL Direct - All 6 versions
J Webster, G Piscitelli, A Polli, A D'Alberton, … - CLINICAL ENDOCRINOLOGY-OXFORD-, 1992 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 37 - Related articles - BL Direct - All 4 versions
J Webster, G Piscitelli, A Polli, A D'Alberton, … - CLINICAL ENDOCRINOLOGY-OXFORD-, 1993 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 31 - Related articles - BL Direct - All 4 versions
JK Liu, WT Couldwell - Neurosurgical Focus, 2004 - medscape.com Prolactin-secreting pituitary adenomas prolactinomas are the most common type of
functional pituitary tumor. Treatment of hyperprolactinemia is indicated because
of the consequences of infertility, gonadal dysfunction, and osteoporosis. ... Cited by 27 - Related articles - All 7 versions
